Intrommune
Greg Plunkett is an independent consultant providing support for the allergy immunotherapy field. He has over 40 years of experience with allergen manufacturing, quality control and pharma regulations with 18 publications and over 68 abstracts. He most recently was the Director of the Allergy Research Lab for ALK USA allergen extract manufacturing since 2001. His focus was on the characterization of allergen source material and finished products. Prior to joining ALK, Dr. Plunkett served as a Research Scientist in the laboratories of Hollister-Stier where in addition to allergen characterization, he developed in vitro tests for diagnosing allergy. Dr. Plunkett sits on allergy immunotherapy committees for national allergy societies, is the Science officer for the US Allergen Manufacturers Association and has twice been a member of the FDA Allergenics Products Advisory Committee. Dr. Plunkett has a bachelor’s degree in Chemistry from Cal State University, Fullerton and a Ph.D. in biochemistry from Washington State University.
This person is not in the org chart
This person is not in any offices
Intrommune
Intrommune Therapeutics is a specialty biopharmaceutical company located in New York, NY. Intrommune is developing a revolutionary new treatment platform for food allergies that is safe, effective and convenient.